510(k) Report

FDA applicant

Magnolia Medical Technologies

Seattle, WA4 decisions2020–20252 recalls

FDA records 4 decisions for Magnolia Medical Technologies (Seattle, WA) from 2020 to 2025: 4 510(k) clearances. Most are in product codes JKA (Tubes, Vials, Systems, Serum Separators, Blood…) and FPA (Set, Administration, Intravascular). Since 2016 its 510(k)s took a median of 157 days from receipt to decision, against 173 for FDA’s reviews in the same codes and years. Its devices cite 3 predicates, 2 of them its own earlier devices. 2 recalls are linked to its devices.

FDA’s records also spell it “Magnolia Medical Technologies, Inc.”.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, clinical chemistry panel, where it files most

How often FDA has decided Magnolia Medical Technologies’s devices, and how often a recall has named them.

FDA decisions per year

1in 2025

2020: 22022: 12025: 1
2020high 2 (2020) · low 0 (2021)2026

2026 so far, outlined.

Recalls per year

2in 2021

2021: 2
2020high 2 (2021) · low 0 (2020)2026

Class I Class II/III not classified

FIG. 1 — Magnolia Medical Technologies by year, 2020–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Magnolia Medical Technologies’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report